<p>BL/6 mice administered with oseltamivir or PBS were assessed for CD8<sup>+</sup> T cell responses to the influenza A viral epitopes (A) D<sup>b</sup>NP<sub>366</sub>, (B) D<sup>b</sup>PA<sub>224</sub>, (C) K<sup>b</sup>PB1<sub>703-711</sub>, (D) D<sup>b</sup>PB1-F2<sub>62-70</sub> and (E) K<sup>b</sup>NS2<sub>114-121</sub> by intracellular IFN-γ staining after a five hour stimulation of splenocytes with cognate peptide. Data represent 9–10 mice per group, analysed over two independent experiments. Epitope-specific CD8<sup>+</sup> T cells directed at (FG) D<sup>b</sup>NP<sub>366</sub>, (HI) D<sup>b</sup>PA<sub>224</sub> were enumerated by tetramer staining in both spleen (GI) and at the site of infection (FH). Data represent 9–10 mice per...
<p>B6 (wild type) or IFITM3 KO mice were seeded with naïve CFSE-labeled OT-I.CD45.1 one day prior in...
<p>(A) groups of 3 (young) and 12 (old) month old mice were primed with 10<sup>5</sup> PFU of MCMV, ...
<p>Mice were infected with LCMV CL-13. At 1.5 d p.i., 0.5 mg IFNAR-1 mAb (αIFNAR-1) or its control i...
<p>(A) Naïve female BL/6 mice were administered either oseltamivir or PBS four hours prior to intran...
<p>Mice were treated with PBS or oseltamivir and infected with influenza virus X31 as in <a href="ht...
<p>Oseltamivir prophylaxis of influenza virus-infected mice results in reduced recruitment of innate...
<div><p>CD8<sup>+</sup> T cells directed against conserved viral regions elicit broad immunity again...
<p>Mice received oseltamivir or PBS 4 hours prior to infection with 10<sup>4</sup> pfu of HK and onc...
<p>Mice were treated with PBS or oseltamivir and infected with influenza virus X31, then rested for ...
<p>(A) Naïve female BL/6 mice were orally administered either 2mg oseltamivir in PBS or PBS alone 4 ...
BACKGROUND: Lung inflammation is a critical determinant of influenza infection outcomes but is seldo...
<p>(A) Total numbers (BAL+MLN+SPL) of virus-specific (K<sup>d</sup>NP<sub>147</sub> positive) CD8 T ...
<p>(A) Pre-gating strategy to identify DC (B–C) DC from the inguinal and mediastinal lymph nodes of ...
<p>10<sup>4</sup> purified CD8 T cells from CD45.1<sup>+</sup> WT or CD45.1<sup>+</sup> NOD2<sup>−/−...
<p>A, OVA<sub>257–264</sub>/K<sup>b+</sup> splenic CD8 T cell population seven days after VSV-OVA in...
<p>B6 (wild type) or IFITM3 KO mice were seeded with naïve CFSE-labeled OT-I.CD45.1 one day prior in...
<p>(A) groups of 3 (young) and 12 (old) month old mice were primed with 10<sup>5</sup> PFU of MCMV, ...
<p>Mice were infected with LCMV CL-13. At 1.5 d p.i., 0.5 mg IFNAR-1 mAb (αIFNAR-1) or its control i...
<p>(A) Naïve female BL/6 mice were administered either oseltamivir or PBS four hours prior to intran...
<p>Mice were treated with PBS or oseltamivir and infected with influenza virus X31 as in <a href="ht...
<p>Oseltamivir prophylaxis of influenza virus-infected mice results in reduced recruitment of innate...
<div><p>CD8<sup>+</sup> T cells directed against conserved viral regions elicit broad immunity again...
<p>Mice received oseltamivir or PBS 4 hours prior to infection with 10<sup>4</sup> pfu of HK and onc...
<p>Mice were treated with PBS or oseltamivir and infected with influenza virus X31, then rested for ...
<p>(A) Naïve female BL/6 mice were orally administered either 2mg oseltamivir in PBS or PBS alone 4 ...
BACKGROUND: Lung inflammation is a critical determinant of influenza infection outcomes but is seldo...
<p>(A) Total numbers (BAL+MLN+SPL) of virus-specific (K<sup>d</sup>NP<sub>147</sub> positive) CD8 T ...
<p>(A) Pre-gating strategy to identify DC (B–C) DC from the inguinal and mediastinal lymph nodes of ...
<p>10<sup>4</sup> purified CD8 T cells from CD45.1<sup>+</sup> WT or CD45.1<sup>+</sup> NOD2<sup>−/−...
<p>A, OVA<sub>257–264</sub>/K<sup>b+</sup> splenic CD8 T cell population seven days after VSV-OVA in...
<p>B6 (wild type) or IFITM3 KO mice were seeded with naïve CFSE-labeled OT-I.CD45.1 one day prior in...
<p>(A) groups of 3 (young) and 12 (old) month old mice were primed with 10<sup>5</sup> PFU of MCMV, ...
<p>Mice were infected with LCMV CL-13. At 1.5 d p.i., 0.5 mg IFNAR-1 mAb (αIFNAR-1) or its control i...